Alcon AG Ownership

ALC Stock  USD 91.90  0.32  0.35%   
Alcon AG holds a total of 494.62 Million outstanding shares. Over half of Alcon AG's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that on April 15, 2025, Representative Julie Johnson of US Congress acquired under $15k worth of Alcon AG's common stock.
Some institutional investors establish a significant position in stocks such as Alcon AG in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Alcon AG, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alcon AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Alcon Stock refer to our How to Trade Alcon Stock guide.

Alcon Stock Ownership Analysis

About 69.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.99. Some equities with similar Price to Book (P/B) outperform the market in the long run. Alcon AG has Price/Earnings To Growth (PEG) ratio of 2.42. The entity last dividend was issued on the 14th of May 2025. The firm had 2:1 split on the June 16, 2011. Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland. Alcon operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 24000 people. For more info on Alcon AG please contact David Endicott at 41 589 112 110 or go to https://www.alcon.com.

Alcon AG's latest congressional trading

Congressional trading in companies like Alcon AG, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Alcon AG by those in governmental positions are based on the same information available to the general public.
2025-04-15Representative Julie JohnsonAcquired Under $15KVerify
2019-04-18Representative Debbie DingellAcquired Under $15KVerify

Alcon AG Outstanding Bonds

Alcon AG issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Alcon AG uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Alcon bonds can be classified according to their maturity, which is the date when Alcon AG has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Alcon AG offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alcon AG's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alcon Ag Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alcon Ag Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alcon AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Alcon Stock refer to our How to Trade Alcon Stock guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alcon AG. If investors know Alcon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alcon AG listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alcon AG is measured differently than its book value, which is the value of Alcon that is recorded on the company's balance sheet. Investors also form their own opinion of Alcon AG's value that differs from its market value or its book value, called intrinsic value, which is Alcon AG's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alcon AG's market value can be influenced by many factors that don't directly affect Alcon AG's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alcon AG's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alcon AG is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alcon AG's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.